Version 2 2024-06-05, 07:39Version 2 2024-06-05, 07:39
Version 1 2022-04-12, 08:18Version 1 2022-04-12, 08:18
journal contribution
posted on 2024-06-05, 07:39authored byRJ Longley, MT White, J Brewster, Zoe Liu, C Bourke, E Takashima, M Harbers, WH Tham, J Healer, CE Chitnis, W Monteiro, M Lacerda, J Sattabongkot, T Tsuboi, I Mueller
Abstract
To achieve malaria elimination, new tools are required to explicitly target Plasmodium vivax. Recently, a novel panel of P. vivax proteins were identified and validated as serological markers for detecting recent exposure to P. vivax within the last 9 months. In order to improve the sensitivity and specificity of these markers, immunoglobulin M (IgM) in addition to immunoglobulin G (IgG) antibody responses were compared with a down-selected panel of 20 P. vivax proteins. IgM was tested using archival plasma samples from observational cohort studies conducted in malaria-endemic regions of Thailand and Brazil. IgM responses to these proteins generally had poorer classification performance than IgG.